4
Changes in Ownership
Bambusa Therapeutics, Inc. Filed Acc 0002160743-26-000013
See remarks acquired 163,596 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Xu Shanshan See remarks | 2026-11-02 | Conversion | +16,358 | 840,277 | I | ||
| Xu Shanshan See remarks | 2026-11-02 | Conversion | +147,238 | 7,562,518 | I | ||
| Derivatives | |||||||
| Xu Shanshan See remarks | 2026-11-02 | Conversion · Series Seed Plus Preferred Stock | −4,155 | 0 | I | ||
| Xu Shanshan See remarks | 2026-11-02 | Conversion · Series Seed Preferred Stock | −10,450 | 0 | I | ||
| Xu Shanshan See remarks | 2026-11-02 | Conversion · Series A-1 Preferred Stock | −1,753 | 0 | I | ||
| Xu Shanshan See remarks | 2026-11-02 | Conversion · Series Seed Plus Preferred Stock | −37,399 | 0 | I | ||
| Xu Shanshan See remarks | 2026-11-02 | Conversion · Series Seed Preferred Stock | −94,050 | 0 | I | ||
| Xu Shanshan See remarks | 2026-11-02 | Conversion · Series A-1 Preferred Stock | −15,789 | 0 | I | ||
Loading xslF345X06/form4-11022026_091124.xml…